Endothelial dysfunction in adults with obstructive sleep apnea

Advances in Cardiology

Volumn 46, Issue , 2011, Pages 139-169

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN 1; NITRIC OXIDE; PROCOAGULANT;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; HYPOXIA; INSULIN RESISTANCE; LEUKOCYTE ADHERENCE; MEDICAL LITERATURE; OBESITY; OXIDATIVE STRESS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP; SLEEP APNEA SYNDROME; SMOKING; SMOOTH MUSCLE FIBER; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VASOCONSTRICTION; VASODILATATION;

ADULT; ANGIOTENSIN II; APOPTOSIS; BIOLOGICAL MARKERS; BLOOD COAGULATION DISORDERS; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE; OXIDATIVE STRESS; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 82755162398     PISSN: 00652326     EISSN: 16622839     Source Type: Book Series    
DOI: 10.1159/000325108     Document Type: Article

References (163)

1. Hirata Y, Nagata D, Suzuki E, Nishimatsu H, Suzuki J, Nagai R: Diagnosis and treatment of endothelial dysfunction in cardiovascular disease. Int Heart J 2010;51:1-6.
2. Yang Z, Ming XF: Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res 2006;4:53-65.
3. Grover- Paez F, Zavalza- Gomez AB: Endothelial dysfunction and cardiovascular risk factors. Diabetes Res Clin Pract 2009;84:1- 10.
4. Vanhoutte PM: Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ J 2009;73: 595-601.
5. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S: Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 2009; 32(suppl 2):S314-S321.
6. McNicholas WT, Bonsigore MR: Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-178. (Pubitemid 46092013)
7. Levy P, Pepin JL, Arnaud C, Baguet JP, Dematteis M, Mach F: Obstructive sleep apnea and atherosclerosis. Prog Cardiovasc Dis 2009;51:400-410.
8. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP: Pathophysiology of sleep apnea. Physiol Rev 2010; 90:47-112.
9. Atkeson A, Yeh SY, Malhotra A, Jelic S: Endothelial function in obstructive sleep apnea. Prog Cardiovasc Dis 2009;51:351-362.
10. Budhiraja R, Parthasarathy S, Quan SF: Endothelialdysfunction in obstructive sleep apnea. J Clin Sleep Med 2007;3:409-415.
11. Foster GE, Poulin MJ, Hanly PJ: Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol 2007;92:51-65. (Pubitemid 46098897)
12. Atkeson A, Jelic S: Mechanisms of endothelial dysfunction in obstructive sleep apnea. Vasc Health Risk Manag 2008;4:1327-1335.
13. Stamatelopoulos K, Karatzi K, Sidossis LS: Noninvasive methods for assessing early markers of atherosclerosis: the role of body composition and nutrition. Curr Opin Clin Nutr Metab Care 2009;12: 467-473.
14. Simon A, Chironi G: The relationship between carotid intima- media thickness and coronary atheros clerosis revisited. Eur Heart J 2007;28:2049-2050. (Pubitemid 47517454)
15. Simon A, Megnien JL, Chironi G: The value of carotid intima- media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol 2010;30:182-185.
16. Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA: Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 2004;169: 354-360. (Pubitemid 38134814)
17. Suzuki T, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Yamauchi M, Kimura H: Obstructive sleep apnea and carotid- artery intima- media thickness. Sleep 2004;27:129-133. (Pubitemid 43906324)
18. Altin R, Ozdemir H, Mahmutyazicioglu K, Kart L, Uzun L, Ozer T, Savranlar A, Aydin M: Evaluation of carotid artery wall thickness with high- resolution sonography in obstructive sleep apnea syndrome. J Clin Ultrasound 2005;33:80-86. (Pubitemid 40194417)
19. Baguet JP, Hammer L, Levy P, Pierre H, Launois S,Mallion JM, Pepin JL: The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 2005;128:3407-3412. (Pubitemid 41698671)
20. Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi- Filho G: Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005;172:613-618. (Pubitemid 41232973)
21. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N, Okada S, Ohta S, Naito H, Adachi M: Increased carotid intima- media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 2005;172:625-630. (Pubitemid 41232975)
22. Phillips C, Hedner J, Berend N, Grunstein R: Diurnal and obstructive sleep apnea influences on arterial stiffness and central blood pressure in men. Sleep 2005;28:604-609. (Pubitemid 40677375)
23. Schulz R, Seeger W, Fegbeutel C, Husken H, Bodeker RH, Tillmanns H, Grebe M: Changes in extracranial arteries in obstructive sleep apnoea. Eur Respir J 2005;25:69-74. (Pubitemid 40207733)
24. Saletu M, Nosiska D, Kapfhammer G, Lalouschek W, Saletu B, Benesch T, Zeitlhofer J: Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSA): association of mild OSA with early atherosclerosis. J Neurol 2006; 253:746-752. (Pubitemid 43980146)
25. Drager LF, Bortolotto LA, Figueiredo AC, Silva BC, Krieger EM, Lorenzi- Filho G: Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest 2007;131: 1379-1386. (Pubitemid 46762342)
26. Tsioufis C, Thomopoulos K, Dimitriadis K, Amfilochiou A, Tousoulis D, Alchanatis M, Stefanadis C, Kallikazaros I: The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects. J Hypertens 2007;25:141-146. (Pubitemid 44885675)
27. Baguet JP, Levy P, Barone- Rochette G, Tamisier R, Pierre H, Peeters M, Mallion JM, Pepin JL: Masked hypertension in obstructive sleep apnea syndrome. J Hypertens 2008;26:885-892. (Pubitemid 351520975)
28. Kohler M, Craig S, Nicoll D, Leeson P, Davies RJ, Stradling JR: Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. Am J Respir Crit Care Med 2008;178: 984-988.
29. Protogerou AD, Laaban JP, Czernichow S, Kostopoulos C, Lekakis J, Safar ME, Blacher J: Structural and functional arterial properties in patients with obstructive sleep apnoea syndrome and cardiovascular comorbidities. J Hum Hypertens 2008;22:415-422. (Pubitemid 351712388)
30. Wattanakit K, Boland L, Punjabi NM, Shahar E: Relation of sleep- disordered breathing to carotid plaque and intima- media thickness. Atherosclerosis 2008;197:125-131. (Pubitemid 351273231)
31. Baguet JP, Nadra M, Barone- Rochette G, Ormezzano O, Pierre H, Pepin JL: Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea. Vasc Health Risk Manag 2009;5:1063-1073.
32. Chung S, Yoon IY, Shin YK, Lee CH, Kim JW, Ahn HJ: Endothelial dysfunction and inflammatory reactions of elderly and middle- aged men with obstructive sleep apnea syndrome. Sleep Breath 2009;13:11-17.
33. Drager LF, Bortolotto LA, Krieger EM, Lorenzi- Filho G: Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension 2009;53:64-69.
34. Drager LF, Bortolotto LA, Maki- Nunes C, Trombetta IC, Alves MJ, Fraga RF, Negrao CE, Krieger EM, Lorenzi- Filho G: The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 2010;208:490-495.
35. Turmel J, Series F, Boulet LP, Poirier P, Tardif JC, Rodes- Cabeau J, Larose E, Bertrand OF: Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study. Int J Cardiol 2009;132:203-209.
36. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF: Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007;176:706-712. (Pubitemid 47503079)
37. Saito T, Sugiyama S, Asai K, Yasutake M, Mizuno K: Effects of long- term treatment for obstructive sleep apnea on pulse wave velocity. Hypertens Res 2010; 33:844-849.
38. Van Wijk MJ, Van Bavel E, Sturk A, Nieuwland R: Microparticles in cardiovascular diseases. Cardiovasc Res 2003;59:277-287. (Pubitemid 37272022)
39. Chironi G, Simon A, Hugel B, Del Pino M, Gariepy J, Freyssinet JM, Tedgui A: Circulating leukocytederived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arteri oscler Thromb Vasc Biol 2006;26:2775-2780.
40. Boulanger CM, Amabile N, Tedgui A: Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006; 48:180-186. (Pubitemid 44309805)
41. Nomura S: Dynamic role of microparticles in type 2 diabetes mellitus. Curr Diabetes Rev 2009;5:245-251.
42. Sabatier F, Camoin- Jau L, Anfosso F, Sampol J, Dignat- George F: Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med 2009;13:454-471.
43. El Solh AA, Akinnusi ME, Baddoura FH, Mankowski CR: Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction. Am J Respir Crit Care Med 2007;175: 1186-1191. (Pubitemid 46855461)
44. El Solh AA, Akinnusi ME, Berim IG, Peter AM, Paasch LL, Szarpa KR: Hemostatic implications of endothelial cell apoptosis in obstructive sleep apnea. Sleep Breath 2008;12:331-337.
45. Dyugovskaya L, Polyakov A, Lavie P, Lavie L: Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med 2008;177:544-554. (Pubitemid 351442194)
46. Ayers L, Ferry B, Craig S, Nicoll D, Stradling JR, Kohler M: Circulating cell- derived microparticles in patients with minimally symptomatic obstructive sleep apnoea. Eur Respir J 2009;33:574-580.
47. Jelic S, Lederer DJ, Adams T, Padeletti M, Colombo PC, Factor P, Le Jemtel TH: Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea. Vasc Health Risk Manag 2009;5:909-920.
48. Priou P, Gagnadoux F, Tesse A, Mastronardi ML, Agouni A, Meslier N, Racineux JL, Martinez MC, Trzepizur W, Andriantsitohaina R: Endothelial dysfunction and circulating microparticles from patients with obstructive sleep apnea. Am J Pathol 2010;177:974-983.
49. Goon PK, Watson T, Lip GY: Circulating endothelial cells in obstructive sleep apnea: an important methodological lesson. Am J Respir Crit Care Med 2007;175:1346, author reply 1347. (Pubitemid 46905758)
50. Tzouvelekis A, Kotsianidis I, Steiropoulos P, Bouros D: Role of CD146 in detection of apoptotic circulating endothelial cells in obstructive sleep apnea. Am J Respir Crit Care Med 2007;175:1346-1347, author reply 1347. (Pubitemid 46905759)
51. Zidar N, Jeruc J, Balazic J, Stajer D: Neutrophils in human myocardial infarction with rupture of the free wall. Cardiovasc Pathol 2005;14:247-250. (Pubitemid 41317271)
52. Maianski NA, Maianski AN, Kuijpers TW, Roos D: Apoptosis of neutrophils. Acta Haematol 2004;111: 56-66. (Pubitemid 37499955)
53. Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, Colombo PC, Basner RC, Factor P, Le Jemtel TH: Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008;117:2270-2278.
54. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007. (Pubitemid 41262334)
55. Werner N, Wassmann S, Ahlers P, Schiegl T, Kosiol S, Link A, Walenta K, Nickenig G: Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 2007;102:565-571. (Pubitemid 47578401)
56. Sirker AA, Astroulakis ZM, Hill JM: Vascular progenitor cells and translational research: the role of endothelial and smooth muscle progenitor cells in endogenous arterial remodelling in the adult. Clin Sci (Lond) 2009;116:283-299.
57. De la Pena M, Barcelo A, Barbe F, Pierola J, Pons J, Rimbau E, Ayllon O, Agusti AG: Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome. Respiration 2008;76:28-32. (Pubitemid 351914136)
58. Martin K, Stanchina M, Kouttab N, Harrington EO, Rounds S: Circulating endothelial cells and endothelial progenitor cells in obstructive sleep apnea. Lung 2008;186:145-150.
59. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard- Herman M, Herrington D: Guidelines for the ultrasound assessment of endothelial- dependent flow- mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-265. (Pubitemid 34084631)
60. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK: Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004;169:348-353. (Pubitemid 38134813)
61. Carlson JT, Rangemark C, Hedner JA: Attenuated endothelium- dependent vascular relaxation in patients with sleep apnoea. J Hypertens 1996;14:577-584. (Pubitemid 26161112)
62. Kato M, Roberts- Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, Somers VK: Impairment of endothelium- dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000;102:2607-2610.
63. Lattimore JL, Wilcox I, Skilton M, Langenfeld M, Celermajer DS: Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 2006;61:491-495. (Pubitemid 43901518)
64. Bayram NA, Ciftci B, Keles T, Durmaz T, Turhan S, Bozkurt E, Peker Y: Endothelial function in normotensive men with obstructive sleep apnea before and 6 months after CPAP treatment. Sleep 2009;32:1257-1263.
65. Kushida CA, Morgenthaler TI, Littner MR, Alessi CA, Bailey D, Coleman J Jr, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee- Chiong T, Owens J, Pancer JP: Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep 2006;29:240-243. (Pubitemid 44019978)
66. Itzhaki S, Dorchin H, Clark G, Lavie L, Lavie P, Pillar G: The effects of 1- year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest 2007;131:740-749. (Pubitemid 46446865)
67. Trzepizur W, Gagnadoux F, Abraham P, Rousseau P, Meslier N, Saumet JL, Racineux JL: Microvascular endothelial function in obstructive sleep apnea: impact of continuous positive airway pressure and mandibular advancement. Sleep Med 2009;10:746-752.
68. Forstermann U, Munzel T: Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006;113:1708-1714.
69. Lerman A, Zeiher AM: Endothelial function: cardiac events. Circulation 2005;111:363-368. (Pubitemid 40165345)
70. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S: Endothelium- dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 2009;157:527-536.
71. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, Lam WK: Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162:2166-2171. (Pubitemid 32051681)
72. Schulz R, Schmidt D, Blum A, Lopes- Ribeiro X, Lucke C, Mayer K, Olschewski H, Seeger W, Grimminger F. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000;55:1046-1051.
73. Alonso- Fernandez A, Garcia- Rio F, Arias MA, Hernanz A, de la Pena M, Pierola J, Barcelo A, Lopez- Collazo E, Agusti A. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 2009;64:581-586.
74. Bayazit YA, Yilmaz M, Erdal E, Ciftci TU, Ceylan A, Kokturk O, Celenk F, Kemaloglu YK: Role of nitric oxide synthase gene intron 4 and exon 7 polymorphisms in obstructive sleep apnea syndrome. Eur Arch Otorhinolaryngol 2009;266:449-454.
75. Szabo C: Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. Br J Pharmacol 2009;156:713-727.
76. Muller G, Morawietz H. Nitric oxide, NAD(P)H oxidase, and atherosclerosis. Antioxid Redox Signal 2009;11:1711-1731.
77. Sydow K, Munzel T: ADMA and oxidative stress.Atheroscler Suppl 2003;4:41-51. (Pubitemid 38234494)
78. Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E, Santa T, Imai K, Hashimoto M, Yoshizumi M, Ouchi Y: Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure - possible involvement of nitric oxide and asymmetric NG, NG- dimethylarginine. Circ J 2005;69:221-226. (Pubitemid 40313045)
79. Ozkan Y, Firat H, Simsek B, Torun M, Yardim- Akaydin S: Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apneahypopnea syndrome (OSAHS). Sleep Breath 2008; 12:149-154. (Pubitemid 351486675)
80. Barcelo A, de la Pena M, Ayllon O, Vega- Agapito MV, Pierola J, Perez G, Gonzalez C, Alonso A, Agusti AG: Increased plasma levels of asymmetric dimethylarginine and soluble CD40 ligand in patients with sleep apnea. Respiration 2009;77:85-90.
81. Patt BT, Jarjoura D, Haddad DN, Sen CK, Roy S, Flavahan NA, Khayat RN: Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea. Am J Respir Crit Care Med 2010;182: 1540-1545.
82. Cortelli P, Parchi P, Sforza E, Contin M, Pierangeli G, Barletta G, Lugaresi E: Cardiovascular autonomic dysfunction in normotensive awake subjects with obstructive sleep apnoea syndrome. Clin Auton Res 1994;4:57-62. (Pubitemid 24157819)
83. Lai CJ, Yang CC, Hsu YY, Lin YN, Kuo TB: Enhanced sympathetic outflow and decreased baroreflex sensitivity are associated with intermittent hypoxiainduced systemic hypertension in conscious rats. J Appl Physiol 2006;100:1974-1982. (Pubitemid 43845873)
84. Sverrisdottir YB, Jansson LM, Hagg U, Gan LM: Muscle sympathetic nerve activity is related to a surrogate marker of endothelial function in healthy individuals. PLoS One 2010;5:e9257.
85. Grote L, Kraiczi H, Hedner J: Reduced alpha- and beta(2)- adrenergic vascular response in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000;162:1480-1487.
86. Hayes MJ, Qing F, Rhodes CG, Rahman SU, Ind PW, Sriskandan S, Jones T, Hughes JM: In vivo quantification of human pulmonary betaadrenoceptors: effect of beta- agonist therapy. Am J Respir Crit Care Med 1996;154:1277-1283.
87. Mills PJ, Dimsdale JE, Coy TV, Ancoli- Israel S, Clausen JL, Nelesen RA: Beta 2- adrenergic receptor characteristics in sleep apnea patients. Sleep 1995; 18:39-42.
88. Nelesen RA, Dimsdale JE, Mills PJ, Clausen JL, Ziegler MG, Ancoli- Israel S: Altered cardiac contractility in sleep apnea. Sleep 1996;19:139-144. (Pubitemid 26102850)
89. Mills PJ, Dimsdale JE, Ancoli- Israel S, Clausen J, Loredo JS: The effects of hypoxia and sleep apnea on isoproterenol sensitivity. Sleep 1998;21:731-735. (Pubitemid 28516164)
90. Dhaun N, Goddard J, Webb DJ: The endothelin system and its antagonism in chronic kidney disease. J Am Soc Nephrol 2006;17:943-955.
91. Marasciulo FL, Montagnani M, Potenza MA. Endothelin- 1: the yin and yang on vascular function. Curr Med Chem 2006;13:1655-1665. (Pubitemid 43821697)
92. Watts SW: Endothelin receptors: what's new and what do we need to know? Am J Physiol Regul Integr Comp Physiol 2010;298:R254-R260.
93. Schorlemmer A, Matter ML, Shohet RV: Cardioprotective signaling by endothelin. Trends Cardiovasc Med 2008;18:233-239.
94. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK: Effects of obstructive sleep apnea on endothelin- 1 and blood pressure. J Hypertens 1999;17:61-66. (Pubitemid 29086189)
95. Grimpen F, Kanne P, Schulz E, Hagenah G, Hasenfuss G, Andreas S: Endothelin- 1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J 2000;15:320-325. (Pubitemid 30085960)
96. Moller DS, Lind P, Strunge B, Pedersen EB: Abnormal vasoactive hormones and 24- hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003;16:274-280. (Pubitemid 36384754)
97. Jordan W, Reinbacher A, Cohrs S, Grunewald RW, Mayer G, Ruther E, Rodenbeck A: Obstructive sleep apnea: plasma endothelin- 1 precursor but not endothelin- 1 levels are elevated and decline with nasal continuous positive airway pressure. Peptides 2005;26:1654-1660. (Pubitemid 41169761)
98. Zamarron- Sanz C, Ricoy- Galbaldon J, Gude- Sampedro F, Riveiro- Riveiro A: Plasma levels of vascular endothelial markers in obstructive sleep apnea. Arch Med Res 2006;37:552-555.
99. Gjorup PH, Sadauskiene L, Wessels J, Nyvad O, Strunge B, Pedersen EB: Abnormally increased endothelin- 1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 2007;20:44-52. (Pubitemid 46014056)
100. Gjorup PH, Wessels J, Pedersen EB: Abnormally increased nitric oxide synthesis and increased endothelin- 1 in plasma in patients with obstructive sleep apnoea. Scand J Clin Lab Invest 2008;68:375-385.
101. Saarelainen S, Seppala E, Laasonen K, Hasan J: Circulating endothelin- 1 in obstructive sleep apnea. Endothelium 1997;5:115-118. (Pubitemid 27273680)
102. Hemsen A, Ahlborg G, Ottosson- Seeberger A, Lundberg JM: Metabolism of big endothelin- 1 (1- 38) and (22- 38) in the human circulation in relation to production of endothelin- 1 (1- 21). Regul Pept 1995;55:287-297.
103. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR: Polar secretion of endothelin- 1 by cultured endothelial cells. J Biol Chem 1992;267:16066-16068.
104. Diefenbach K, Kretschmer K, Bauer S, Malzahn U, Penzel T, Roots I, Fietze I: Endothelin- 1 gene variant Lys198Asn and plasma endothelin level in obstructive sleep apnea. Cardiology 2009;112:62-68.
105. Buck D, Diefenbach K, Penzel T, Malzahn U, Roots I, Fietze I: Genetic polymorphisms in endothelinreceptor- subtype- A- gene as susceptibility factor for obstructive sleep apnea syndrome. Sleep Med 2010; 11:213-217.
106. Cheng ZJ, Vapaatalo H, Mervaala E: Angiotensin II and vascular inflammation. Med Sci Monit 2005;11: RA194- RA205. (Pubitemid 40904729)
107. Probstfield JL, O'Brien KD: Progression of cardiovascular damage: the role of renin- angiotensin system blockade. Am J Cardiol 2010;105:10A- 20A.
108. Bader M. Tissue renin- angiotensin- aldosterone systems: targets for pharmacological therapy. Annu Rev Pharmacol Toxicol 2010;50:439-465.
109. Dzau VJ: Theodore Cooper lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001;37:1047-1052. (Pubitemid 32304002)
110. Yavuz D, Koc M, Toprak A, Akpinar I, Velioglu A, Deyneli O, Haklar G, Akalin S: Effects of ACE inhibition and AT1- receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients. J Renin Angiotensin Aldosterone Syst 2003;4:197-203. (Pubitemid 37407169)
111. Rigat B, Hubert C, Alhenc- Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I- converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346. (Pubitemid 20370444)
112. Sayed- Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC: ACE polymorphisms. Circ Res 2006;98:1123-1133. (Pubitemid 43948098)
113. Xiao Y, Huang X, Qiu C, Zhu X, Liu Y: Angiotensin I- converting enzyme gene polymorphism in Chinese patients with obstructive sleep apnea syndrome. Chin Med J (Engl) 1999;112:701-704.
114. Barcelo A, Elorza MA, Barbe F, Santos C, Mayoralas LR, Agusti AG: Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms. Eur Respir J 2001;17: 728-732. (Pubitemid 32492564)
115. Lin L, Finn L, Zhang J, Young T, Mignot E: Angiotensin- converting enzyme, sleep- disordered breathing, and hypertension. Am J Respir Crit Care Med 2004;170:1349-1353. (Pubitemid 39662748)
116. Patel SR, Emma KL, Mignot E, Lin L, Redline S: The association of angiotensin converting enzyme (ACE) polymorphisms with sleep apnea and hypertension. Sleep 2007;30:531-533. (Pubitemid 46668711)
117. Koyama RG, Drager LF, Lorenzi- Filho G, Cintra FD, Pereira AC, Poyares D, Krieger JE, Castro RM, Tufik S, de Mello MT, Pedrazzoli M: Reciprocal interactions of obstructive sleep apnea and hypertension associated with ACE I/D polymorphism in males. Sleep Med 2009;10:1107-1111.
118. Kizawa T, Nakamura Y, Takahashi S, Sakurai S, Yamauchi K, Inoue H: Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea. Eur Respir J 2009;34:1390-1398.
119. Kraiczi H, Hedner J, Peker Y, Carlson J: Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 2000;89:493-498. (Pubitemid 30637094)
120. Benjamin JA, Moller M, Ebden P, Bartle I, Lewis KE: Serum angiotensin converting enzyme and the obstructive sleep apnea hypopnea syndrome. J Clin Sleep Med 2008;4:325-331.
121. Levy P, Pepin JL, Arnaud C, Tamisier R, Borel JC, Dematteis M, Godin- Ribuot D, Ribuot C: Intermittent hypoxia and sleep- disordered breathing: current concepts and perspectives. Eur Respir J 2008;32:1082-1095.
122. Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J: Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea- induced hypoxemia during sleep. Chest 2001;119:1085-1091. (Pubitemid 32679435)
123. Cross MD, Mills NL, Al- Abri M, Riha R, Vennelle M, Mackay TW, Newby DE, Douglas NJ: Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. Thorax 2008;63:578-583. (Pubitemid 351969249)
124. Chung S, Yoon IY, Lee CH, Kim JW: The association of nocturnal hypoxemia with arterial stiffness and endothelial dysfunction in male patients with obstructive sleep apnea syndrome. Respiration 2010;79:363-369.
125. Jurado- Gamez B, Fernandez- Marin MC, Gomez- Chaparro JL, Munoz- Cabrera L, Lopez- Barea J, Perez- Jimenez F, Lopez- Miranda J. Relationship of oxidative stress and endothelial dysfunction in sleep apnoea. Eur Respir J 2011;37:873-879.
126. Monneret D, Pepin JL, Godin- Ribuot D, Ducros V, Baguet JP, Levy P, Faure P: Association of urinary 15- F2t- isoprostane level with oxygen desaturation and carotid intima- media thickness in nonobese sleep apnea patients. Free Radic Biol Med 2010;48: 619-625.
127. Grebe M, Eisele HJ, Weissmann N, Schaefer C, Tillmanns H, Seeger W, Schulz R: Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 2006;173: 897-901.
128. El Solh AA, Saliba R, Bosinski T, Grant BJ, Berbary E, Miller N: Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 2006;27:997-1002. (Pubitemid 44911115)
129. Fried SK, Bunkin DA, Greenberg AS: Omental and subcutaneous adipose tissues of obese subjects release interleukin- 6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998;83:847-850. (Pubitemid 28496456)
130. Hotamisligil GS: Mechanisms of TNF- alphainduced insulin resistance. Exp Clin Endocrinol Diabetes 1999;107:119-125.
131. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808. (Pubitemid 38063703)
132. Hopkins TA, Ouchi N, Shibata R, Walsh K: Adiponectin actions in the cardiovascular system. Cardiovasc Res 2007;74:11-18. (Pubitemid 46366942)
133. Trayhurn P, Wang B, Wood IS: Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 2008;100:227-235.
134. Knudson JD, Dincer UD, Zhang C, Swafford AN Jr, Koshida R, Picchi A, Focardi M, Dick GM, Tune JD: Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol 2005;289:H48-H56. (Pubitemid 40934081)
135. Knudson JD, Payne GA, Borbouse L, Tune JD: Leptin and mechanisms of endothelial dysfunction and cardiovascular disease. Curr Hypertens Rep 2008;10:434-439.
136. Goldberg RB: Cytokine and cytokine- like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009;94:3171-3182.
137. Zhang H, Park Y, Wu J, Chen X, Lee S, Yang J, Dellsperger KC, Zhang C: Role of TNF- alpha in vascular dysfunction. Clin Sci (Lond) 2009;116:219-230.
138. Csiszar A, Wang M, Lakatta EG, Ungvari Z. Inflammation and endothelial dysfunction during aging: role of NF- kappaB. J Appl Physiol 2008;105: 1333-1341.
139. Kim JA, Montagnani M, Koh KK, Quon MJ: Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113:1888-1904. (Pubitemid 43739401)
140. Goldstein BJ, Scalia RG, Ma XL: Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med 2009;6:27-35.
141. Gustafson B: Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010;17:332-341.
142. Han SH, Sakuma I, Shin EK, Koh KK: Antiatherosclerotic and anti- insulin resistance effects of adiponectin: basic and clinical studies. Prog Cardiovasc Dis 2009;52:126-140.
143. Amir O, Alroy S, Schliamser JE, Asmir I, Shiran A, Flugelman MY, Halon DA, Lewis BS: Brachial artery endothelial function in residents and fellows working night shifts. Am J Cardiol 2004;93:947-949. (Pubitemid 38429616)
144. Takase B, Akima T, Uehata A, Ohsuzu F, Kurita A: Effect of chronic stress and sleep deprivation on both flow- mediated dilation in the brachial artery and the intracellular magnesium level in humans. Clin Cardiol 2004;27:223-227. (Pubitemid 38451159)
145. Van Leeuwen WM, Lehto M, Karisola P, Lindholm H, Luukkonen R, Sallinen M, Harma M, Porkka- Heiskanen T, Alenius H: Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL- 17 and CRP. PLoS One 2009;4:e4589.
146. Sauvet F, Leftheriotis G, Gomez- Merino D, Langrume C, Drogou C, Van Beers P, Bourrilhon C, Florence G, Chennaoui M: Effect of acute sleep deprivation on vascular function in healthy subjects. J Appl Physiol 2010;108:68-75.
147. Frey DJ, Fleshner M, Wright KP Jr: The effects of 40 hours of total sleep deprivation on inflammatory markers in healthy young adults. Brain Behav Immun 2007;21:1050-1057. (Pubitemid 47496127)
148. Dinges DF, Douglas SD, Zaugg L, Campbell DE, McMann JM, Whitehouse WG, Orne EC, Kapoor SC, Icaza E, Orne MT: Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J Clin Invest 1994;93:1930-1939. (Pubitemid 24143070)
149. Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, Chrousos GP: Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004;89:2119-2126. (Pubitemid 38619840)
150. Wolff B, Volzke H, Schwahn C, Robinson D, Kessler C, John U: Relation of self- reported sleep duration with carotid intima- media thickness in a general population sample. Atherosclerosis 2008;196:727-732.
151. Mullington JM, Haack M, Toth M, Serrador JM, Meier- Ewert HK: Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis 2009;51:294-302.
152. Patel SR: Sleep - an affair of the heart. Sleep 2009; 32:289-290.
153. Knutson KL: Impact of sleep and sleep loss on glucose homeostasis and appetite regulation. Sleep Med Clin 2007;2:187-197.
154. Van Cauter E, Holmback U, Knutson K, Leproult R, Miller A, Nedeltcheva A, Pannain S, Penev P, Tasali E, Spiegel K: Impact of sleep and sleep loss on neuroendocrine and metabolic function. Horm Res 2007;67(suppl 1):2-9.
155. Al Lawati NM, Patel SR, Ayas NT: Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration. Prog Cardiovasc Dis 2009;51:285-293.
156. Avogaro A, de Kreutzenberg SV, Fadini G: Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. Diabetes Res Clin Pract 2008;82(suppl 2):S94-S101.
157. Jelic S, Lederer DJ, Adams T, Padeletti M, Colombo PC, Factor PH, Le Jemtel TH: Vascular inflammation in obesity and sleep apnea. Circulation 2010; 121:1014-1021.
158. Vgontzas AN, Bixler EO, Chrousos GP: Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005;9:211-224. (Pubitemid 40694188)
159. Nieto FJ, Peppard PE, Young TB: Sleep disordered breathing and metabolic syndrome. WMJ 2009;108: 263-265.
160. Nock NL, Li L, Larkin EK, Patel SR, Redline S: Empirical evidence for 'syndrome Z': a hierarchical 5- factor model of the metabolic syndrome incorporating sleep disturbance measures. Sleep 2009;32: 615-622.
161. Dematteis M, Godin- Ribuot D, Arnaud C, Ribuot C, Stanke- Labesque F, Pepin JL, Levy P:Cardiovascular consequences of sleep- disordered breathing: contribution of animal models to understanding the human disease. ILAR J 2009;50:262-281.
162. Kanagy NL: Vascular effects of intermittent hypoxia. ILAR J 2009;50:282-288.
163. Touyz RM: Recent advances in intracellular signaling in hypertension. Curr Opin Nephrol Hypertens 2003;12:165-174. (Pubitemid 36288317)